Clinical Trials Browser

Phase 2 × Terminated × Arthritis, Rheumatoid × Clear all

NCT03001219 2020-01-29

A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Phase 2 Terminated

109 enrolled 24 charts

Arthritis, Rheumatoid

NCT02102594 2019-12-03

TAVAB

Phase 2 Terminated

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Myasthenia Gravis

NCT02882087 2019-04-03

A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis

Phase 2 Terminated

Arthritis, Rheumatoid, Lymphoma, Follicular

NCT02862574 2018-06-27

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Phase 2 Terminated

15 enrolled 11 charts

Arthritis, Rheumatoid

NCT01390545 2016-04-13

VELVET

Phase 2 Terminated

Arthritis, Rheumatoid

NCT00537667 2009-11-26

The SPECTRA Study

Phase 2 Terminated

Arthritis, Rheumatoid, Inflammation